New ARCI Chair Calls For Unity And Suggests HISA Reform

Commissioner Doug Moore, the new Chair of the Association of Racing Commissioners International, made inaugural remarks Monday. Per a release from the ARCI, Moore called for unity amongst the racing industry along with reforms to HISA.

Speaking about how penalties are assessed, Moore noted: “Previously, these fines varied from jurisdiction to jurisdiction, creating an illusion of inconsistent application of the rules. But the fact of the matter is that uniform fines are anything but uniform. Fines were and need to be assessed based on the financial structure of individual tracks. An equal fine assessed to a trainer at a track running for a purse structure of up to $500,000 per day is not the same as one given to a trainer racing where the daily purses are $100,000 per day.”

Moore's full remarks can be viewed on the ARCI website.

The post New ARCI Chair Calls For Unity And Suggests HISA Reform appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

HISA Town Hall: Regulatory Reach, Environmental Contamination, Lab Variability and More Discussed

Trainers Ron Moquett and Dale Romans joined Horseracing Integrity and Safety Act (HISA) CEO, Lisa Lazarus, on the agency's virtual town hall Monday. Both trainers sit on the HISA Horsemen's Advisory Group.

A good portion of the HISA Town Hall was spent emphasizing the role of the horsemen's advisory group as a vehicle for potential change and modification in HISA's regulatory framework, having driven tweaks to the federal authority's rules on things like pre-race electrolyte use and looser sanctions for positives related to human substances of abuse (more on that lower down).

“There's a lot of conversation right now around veterinary inspections and vet scratches, and how HISA can make a positive impact,” Lazarus added.

“Those are state processes and state judgments. But HISA, we believe, can do some things to make it better for all parties,” Lazarus added. “That's something we're talking a lot about.”

Below are summaries of some of the key portions of the Q&A.

Q: Should HISA's Remit be Broadened to Police the Sales? 

The question of whether HISA should broaden its regulatory reach to encompass the sales has been much discussed ever since Jeffrey Englehart faced a possible two-year suspension after one of his horses tested positive for clenbuterol.

Englehart argued that he did not give the horse the drug and that it had been given prior to the horse's purchase at the OBS auction a few months beforehand. A subsequent segmented hair test revealed that the clenbuterol had indeed been administered before Englehart became the trainer.

In discussing the topic, Lazarus explained that the act is written so that racehorses fall under HISA oversight only when they record their first official workout.

“And that's been interpreted to mean the first published work in Equibase,” said Lazarus. “There's some question about whether or not breeze shows would qualify, and they might, but we haven't got to that point just yet.”

Lazarus further explained that in October, she met with representatives from the three leading sales companies. “And they agreed to work together to come up with an anti-doping program that aligned with HISA, so that there's a sensible journey from weanling, yearling, 2-year-old, and then to horses of racing age.”

Both trainers argued that a strong case could be made for HISA to police the horse sales, though Moquett voiced reservations about the practicalities of such a program, like the possible licensure of parties handling horses in their formative years.

“There's a lot of information [that would need to be] gathered about working with these horses that all of a sudden is require daily… when we eventually get these horses,” said Moquett.

“Once we open that Pandora's Box, now all of a sudden we're going to require people to list who the owners are. You're going to require trainers and the consignors to have a license. You're going to start looking into places you've never looked,” Moquett added.

“I think Pandora's Box should have been opened a long time ago,” Romans responded, before broaching the topic of greater transparency on corrective surgeries performed on youngstock prior to the sales.

Q: Steps Taken to Prevent Environmental Contamination?

Another key area of concern among stakeholders is that of inadvertent contamination through the horse's environment.

“Everyone needs to play a part in making sure that we're delivering a clean and sterile—as sterile as possible—environment,” said Lazarus, before ticking off various points of address, some of which were included in a recent letter to the editor.

She said that the overall cleanliness of test barns—which are overseen by HIWU—has improved since the start of the ADMC program.

“However, when it comes to other common areas like receiving barns, that is something that needs a lot of work,” Lazarus admitted.

As such, the receiving barn is now part of the racetrack accreditation program, she said. HIWU investigators are also performing daily spot checks to determine which racetracks might not be stepping up to the task.

“We now have the opportunity to launch an investigation if we believe that, based on positive tests, there may be a contamination risk at a particular racecourse,” said Lazarus. “We also have mobile testing packs where we can test straw, soil to see whether or not we're finding substances that shouldn't be in a horse's environment.”

Q: Is a Possible 60-day Penalty Still too Onerous for Substances of Human Abuse Violations?

Under a proposed rule change, a first time violation for a positive test concerning a human substance of abuse like cocaine or methamphetamine has been lessened to a maximum 60-days. But is this still too onerous? Should it be closer to something like 14 days?

“Sixty days is really a cap,” said Lazarus, before adding that determining a possible source for the positive test is key to receiving a lesser penalty.

Also important is for stakeholders to illustrate to regulators what steps they've taken to mitigate the chances of inadvertent environmental contamination, like barring staff from urinating in the stalls and requiring them to wash their hands before mixing feed, said Lazarus.

“One of the things that struck me when I visited Ron [Moquett's] stable at Oaklawn is he has a huge poster in his barn that says, 'if you urinate in the stables, you will be fired,'” said Lazarus. “That's something, if Ron has a positive test, that would be a favorable consideration. He's contributing to what we're all trying to do which is reduce the likelihood of anything that shouldn't be in a horse's system getting into a horse's system.”

Moquett followed that up by saying how, “If you get a positive, it's very important you address the definition of how you think it got there” with HIWU.

“Before you get mad and start throwing stuff, the first thing you've got to write is the truth as you first saw it,” Moquett added, emphasizing how feigning ignorance as to the possible source of the contamination won't cut it under the new federal regime.

“Just let them know that you are conscious of the opportunities for a bad test, and that you're doing everything in your power to [prevent it],” Moquett added.

What other steps should be taken in the event of a positive test for a human substance of abuse, or for an atypical finding?

The panelists recommended that responsible parties first reach out to Alan Foreman, the horsemen's ombudsman. Hard-up stakeholders can also take advantage of a panel of pro-bono attorneys.

Not all who apply will be eligible. “But we've never denied anybody who has actually applied for pro-bono counsel to date,” said Lazarus.

Q: Why is HISA Using so Many Different Labs When Lab Variability is Such a Concern?

The TDN reported last year that a variety of differences between the laboratories—from different testing equipment to different testing methodologies to different sets of staff interpreting the results—mean that they can screen for different numbers of substances, and have varying abilities to screen for the same substances, outside of some 300 core analytes.

“The way that law is written, we're required to give the state where the testing takes place the opportunity to put their lab forward,” said Lazarus, adding how, if the lab in question fails to meet performance specifications, HISA is not required to use it.

With the recent news that HISA is no longer using the services of the University of Kentucky's Equine Analytical Chemistry Laboratory, there are now five labs used under HISA's Anti-Doping and Medication Control (ADMC) program.

“I think with five labs we can get really consistent results,” said Lazarus. “[But] if we can get down to a point where the samples… [can be processed] by three or so labs, that would be preferable.”

The Racing Medication and Testing Consortium (RMTC) currently conducts the lab accreditation process every two years. HIWU is working to take over that process.

Q: Is HISA Working on a Universal Owner-Trainer license?

Despite HISA requiring stakeholders to apply for a federal license, owners, trainers and other industry participants are still required to apply state-by-state for individual licenses. That might change.

“That is absolutely something on our radar, and we know that that would be a huge benefit to the horsemen,” said Lazarus. “Once we get the fundamentals of HISA in place to deliver it working well, and working smoothly, that is an area we will try to be helpful on.”

The horsemen's advisory group, said Moquett, brings the topic up once every two weeks.

“If this is going to be a truly uniform industry, then it needs to start with the very first thing, which is the licensing,” he said. “I think it's an odd deal we haven't fixed it yet.”

Q: Is the Prohibition of Toe Grabs Warranted?

While HISA generally prohibits the use of toe grabs, it offers an exemption permitting the use of traction devices in the form of either a full outer rim shoe (up to 4 mm in height) or a toe grab (up to 4 mm in height) on hindlimbs on the dirt.

The prohibition on toe grabs, said Lazarus, was based on science and research. “Internationally, toe grabs haven't been allowed for quite a long time,” she added. “The U.S. was the last racing jurisdiction to have regulations around toe grabs.”

When asked if further toe grab allowances should be given when it comes to deeper dirt surfaces, Lazarus argued that the data suggests the prohibition has been successful.

“Probably the racetrack that had the biggest complaints about this rule was Prairie Meadows, and they went from in 2022 a 2.39 [fatalities per 1000 starts rate], a much higher fatality rate. And this year, they were exceptional—they were 1.14,” said Laazarus. “I'm not suggesting the whole reason is to do with toe grabs, but at least the data shows they're not worse off with that rule than they were previously.”

The post HISA Town Hall: Regulatory Reach, Environmental Contamination, Lab Variability and More Discussed appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Jonathan Wong Still Searching For First Win In Louisiana

Trainer Jonathan Wong, who was hit with a two-year suspension by the Horseracing Integrity and Welfare Unit (HIWU) for a metformin positive, has resurfaced in Louisiana, where he has 15 horses at a private training center but has yet to visit the winner's circle. Wong sent out his first starter in Louisiana on Feb. 13. But the same trainer who had one of the biggest stables in Northern California has struggled there, sending out just five horses without a winner.

The plaintiff states of Louisiana and West Virginia won a preliminary injunction in federal court in July that will keep the Horseracing Integrity and Safety Act (HISA) Authority's rules from being implemented in those two states until a lawsuit challenging the constitutionality of HISA gets decided in full. Because he was not under a suspension issued by the Louisiana Racing Commission, Wong is being allowed to compete in the Bayou State.

Fair Grounds, which is owned by Churchill Downs Inc., did not give Wong any stalls but is allowing him to race.

Wong did not start a horse between July 1 and Feb. 13, when he sent out his first Louisiana runner, Desoto's War (Warrior's Reward). He has made just four starts at Fair Grounds and one at Delta Downs.

According to one of his owners, Brent Malmstrom, who is helping with Wong's legal fight, Wong had 141 horses before he was suspended.

Malmstrom and Wong have maintained that the trainer is innocent because the positive for the drug, which is used in humans to treat Type II diabetes, was a matter of environmental contamination.

Wong did not return phone calls from the TDN seeking comment.

“Jonathan Wong may have done some things in the past,” he said. “I can't speak to that. All I can speak to is this: he didn't do this. We don't know where the drug came from. It's odd that at point in time when all this happened almost half of the metformin positives occurred at Horseshoe Indianapolis.”

The horse that tested positive was Heaven and Earth (Gormley) and the positive was found after the filly won a June 1 maiden special weight race at Horseshoe Indianapolis.

Malmstrom acknowledged that this has been a difficult situation for Wong.

“The sad thing about this whole thing is that this cost him his marriage,” he said. “He's got four little children. He's doing whatever he can to survive as I, along with our lawyers, work on the legal side to figure out how to get relief.”

Malmstrom said that most of the horses Wong trained before the suspension have been sent to other trainers.

“He lost his entire business,” he said. “The bulk of the horses he has in Louisiana are mine. I don't turn my back on people when they're at their lowest point in life. Louisiana has been incredibly welcoming and we thank them. People deserve an opportunity to defend themselves and should have the right to earn a living while they are defending themselves. That's a fundamental thing.”

The Fair Grounds meet ends on March 24. Malmstrom said that after Fair Grounds closes Wong will focus on the meet at Evangeline Downs, which opens April 7.

Wong has been training since 2014 and has 1,194 career wins. His best year came in 2021, when he saddled 236 winners and won at a rate of 23%.

The post Jonathan Wong Still Searching For First Win In Louisiana appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Open Letter to the Industry: Lisa Lazarus on Contamination

Like many of you, I read Rusty Arnold's open letter about his positive test with interest, and carefully considered the concerns that he identified. Also, like many of you, I am privileged to personally know, and respect Rusty, so I do not take his criticisms lightly. Rusty identified some of the challenges inherent in administering an equine anti-doping and medication control (“ADMC”) program that is efficient, effective, and fair. However, it is important to note that those same challenges existed long before HISA and HIWU came onto the scene. In fact, there is no difference whatsoever between the prohibition of, and the testing for, Tramadol (the substance found in Rusty's horse) pre- and post-HISA, nor for the application of the trainer responsibility rule. There is a difference in the sanction, however, which is less severe under HISA. But more importantly, HISA is doing, and will continue to do, whatever it takes to help make our ADMC Program as effective and fair as it can be.

Let me start by laying out the relevant history of Tramadol, an opioid analgesic, in horseracing. Tramadol has always been a prohibited substance under ARCI rules; it was originally a Class A penalty and was changed to Class B in March 2016. In fact, Carol Cobb, a Kentucky trainer, was ordered to serve a 180-day suspension in 2021 for Tramadol (the violation arose prior to March 2016.)   Every international racing jurisdiction bans Tramadol. Under FEI rules (sport horses), Tramadol is classified as a doping–not medication–substance, and a positive test yields a presumptive two-year ban. Under HISA, Tramadol is a Class B violation because HISA's ADMC Committee recognized that there are legitimate indications for the use of Tramadol in a horse outside of a race.  A Tramadol positive now comes with a 15-day suspension, which can be reduced to seven days if the trainer accepts the consequences without a legal challenge (which is what Rusty opted to do in this case). HIWU testing specifications for Tramadol are consistent with TOBA's Graded Stakes testing which were in place prior to the implementation of the HISA ADMC Program. Kentucky samples were previously tested to the TOBA standards, as the KHRC did not distinguish between stakes and non-stakes races when testing for Tramadol. So, put simply, nothing has changed regarding the treatment of Tramadol in Kentucky, except that HISA has a more lenient sanction than previously applicable to Kentucky trainers.

One of two things is true for any substance: it either has a legitimate, medically justified use in Thoroughbreds and is permitted to be administered properly–or it doesn't, regardless of whether it's been proven to enhance performance. If a substance has no legitimate therapeutic use, then as an industry we need to ensure these substances are not permitted in a horse's system–whether intentionally or unintentionally. In addition, while horsemen's fears are understandable, in truth the risk of “contamination” causing a positive test is exceedingly low.  Nonetheless, HISA firmly believes that maintaining a backstretch free of contamination is a responsibility that must be shared amongst all racing stakeholders, and not fall exclusively on horsemen's shoulders.

So, what are HISA and HIWU currently doing to help protect horsemen from the risk of contamination?

 The Atypical Findings Policy: This program applies to environmental contaminants (e.g., ractopamine, caffeine) and hormones that the horse can produce on its own (e.g., testosterone). The full list of Atypical Findings substances can be found here. HISA Anti-Doping and Medication Control Program Atypical Findings Policy – HIWU.  If any of those substances are detected in a horse's sample, HIWU recognizes that they may likely be the result of contamination, and an investigation is initiated to determine the likely source or cause of the positive test. If HIWU is satisfied that the likely source of the positive was contamination, the trainer is never charged with a violation, and it is never made public.  Since HIWU took over testing nine months ago, there have been 35 positive tests suspected of being environmental contamination and only two have been pursued as violations. The public has not heard of these positive tests, because they are disposed of confidentially; in short, it's a successful program.

Inadvertent Transfer of Human Drugs of Abuse: This is a modification that HISA made in response to a request from the Horsemen's Advisory Group. This separate protocol applies to a list of substances including cocaine, marijuana, methamphetamine, and oxycodone, and is included in the revised rules sent to the Federal Trade Commission.[1] If any of those drugs are detected in a horse's sample, the expectation is that it is likely inadvertent human transfer, and, assuming that the new rules are approved, the ineligibility period will be capped at 60 days (unless of course there are concerns, based upon the available evidence, that the drug may have been intentionally administered.). While HISA awaits the approval of the new rules, HIWU is putting any cases that would result in a shorter ineligibility period under the new rules on hold so that horsemen who have such cases now will be able to benefit from the proposed rule change if it is approved.

All Track Accreditation Visits Now include Cleanliness and Protocol Reviews related to Receiving Barns: Beginning in 2024, once HISA became alerted to Horsemen's concerns, these receiving barn reviews were added as a mandatory requirement at all HISA track accreditation visits.

What are HISA and HIWU planning to do to further protect Horsemen from the risk of contamination?

Random Use of Mobile Drug Test Pouches: Prior to Rusty Arnold's letter, HISA had purchased a significant number of Mobile Drug Test Pouches and is engaging in discussions with HISA's Racetrack Accreditation team and HIWU on how these tests might be deployed under a protocol that would further assist HISA in reducing contamination risk from the backside.

Daily Monitoring by HIWU Investigators: Also previously planned, HIWU investigators stationed at racetracks will employ a daily “to do” list each morning beginning on March 14, which will include the monitoring of common areas for horses, such as receiving barns, for cleanliness.

Continually Review Testing Levels to Address Contamination Issues: As an integral part of HISA's Laboratory Harmonization Initiative, the laboratories continually review testing levels for harmonization, contamination risk, and to ensure consistency with the goals of the ADMC Program.

What can horsemen do to help?

If you See Something, Say Something: As an industry, we are all in this together. We need to know when horsemen observe contamination risks at racetracks if we are to be effective. Please email HISA at keepitclean@hisaus.org with any photos or concerns and we will follow them up immediately. We will keep the source of all such communications strictly confidential.

Maintain a Strict Policy against Urination in the Stables:  We understand that trainers cannot be everywhere and see everything. But your employees should know that urinating in the stalls is prohibited and, if they do, there will be serious consequences.  To be most effective, this should come with reminders to employees to apply hygienic practices, especially handwashing.

If You Can Afford Them and the Racetrack does not Provide Them, Install Webcams in Your Barns: HISA encourages the installation of cameras whenever and wherever possible for an additional layer of risk protection.  HISA will be working to promote more widespread use of cameras at racetracks.

Use Best Efforts to Avoid Hiring Drug Users in Your Barn:  We understand that this may not be obvious when you hire someone, but you should at least have a policy in your stables of avoiding the knowing hiring or retention of drug users.

In sum, HISA and HIWU are fully committed to a fair and effective ADMC program that minimizes the risk of holding anyone without fault accountable for an anti-doping or controlled medication rule violation. If everyone does their part as listed above, we believe that goal is attainable. The HISA ADMC Program will always prioritize the inherent integrity of the program by treating everyone, no matter their stature, the same. We will never allow personal views, or the reputation of any individual racing participant, to supplant what the laboratory reports or related science dictates. (In fact, the Horseracing Integrity and Safety Act prohibits HISA/HIWU from taking any trainer's pre-HISA history–good or bad–into account.) Having the regulator decide who are the “good” guys and who are the “bad” guys, would completely undermine the integrity of any program, and make HISA's mandate entirely futile.

We hope by outlining our program and explaining how trainers can contribute, you will see that we take this issue seriously. HISA and HIWU always welcome constructive industry feedback on our programs as we continue to refine processes and protocols. Feedback can be submitted directly to HISA at feedback@hisaus.org or to the Horsemen's Advisory Group here at horsemenadvisory@hisaus.org.  Please don't hesitate to continue to provide feedback and suggestions of any nature, so that we can work together to reach the important goals that are in the common interest of all industry stakeholders.

 

[1] The full list includes the following substances:  i) Cocaine/Benzoylecognine; (ii) Methamphetamine; (iii) Methaqualone; (iv) Methylenedioxyamphetamine (MDA); (v) Methylenedioxyethylamphetamine (MDEA); (vi) Methylenedioxymethylamphetamine (MDMA);(vii) Oxycodone; (viii) Phencyclidine (PCP); and (ix) Tetrahydrocannabinol (THC).

 

The post Open Letter to the Industry: Lisa Lazarus on Contamination appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Verified by MonsterInsights